Addex Therapeutics Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Addex Therapeutics Ltd. for the month of April 2021. The filing, dated April 8, 2021, serves to incorporate by reference a press release issued on the same date (Exhibit 99.1). The registrant files annual reports under Form 20-F.
Financial Metrics
The provided filing text does not contain specific financial data. It acts as a cover document for a press release and does not disclose revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes
The filing text does not provide details on material changes versus prior periods. The content is limited to the notification of the press release issuance.
Guidance, Outlook, and Risks
Specific guidance, management commentary, risks, contingencies, or unusual items are not detailed in the Form 6-K text itself. These details are contained within the attached press release (Exhibit 99.1), which is not included in the input source.
Key Facts for Investor Verification
- Verify the content of the press release dated April 8, 2021 (Exhibit 99.1) for the specific announcement triggering this filing.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that no financial metrics are disclosed in this specific document; refer to the latest Form 20-F or the attached press release for operational updates.